Evofem Biosciences, Inc. (EVFM)
0.0071
0.00 (0.00%)
USD |
OTCM |
Sep 08, 16:00
Evofem Biosciences Total Assets (Quarterly) : 7.522M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.522M |
| March 31, 2026 | 7.442M |
| December 31, 2025 | 20.27M |
| September 30, 2025 | 13.81M |
| June 30, 2025 | 14.38M |
| March 31, 2025 | 12.88M |
| December 31, 2024 | 23.79M |
| September 30, 2024 | 23.94M |
| June 30, 2024 | 8.551M |
| March 31, 2024 | 8.217M |
| December 31, 2023 | 10.55M |
| September 30, 2023 | 13.32M |
| June 30, 2023 | 14.07M |
| March 31, 2023 | 26.03M |
| December 31, 2022 | 25.16M |
| September 30, 2022 | 42.28M |
| June 30, 2022 | 53.47M |
| March 31, 2022 | 34.57M |
| December 31, 2021 | 42.51M |
| September 30, 2021 | 67.43M |
| June 30, 2021 | 108.75M |
| March 31, 2021 | 93.46M |
| December 31, 2020 | 109.97M |
| September 30, 2020 | 112.33M |
| June 30, 2020 | 135.06M |
| Date | Value |
|---|---|
| March 31, 2020 | 15.64M |
| December 31, 2019 | 28.30M |
| September 30, 2019 | 38.99M |
| June 30, 2019 | 54.42M |
| March 31, 2019 | 3.234M |
| December 31, 2018 | 4.01M |
| September 30, 2018 | 15.03M |
| June 30, 2018 | 26.17M |
| March 31, 2018 | 8.992M |
| December 31, 2017 | 3.952M |
| September 30, 2017 | 6.246M |
| June 30, 2017 | 8.214M |
| March 31, 2017 | 10.73M |
| December 31, 2016 | 12.82M |
| September 30, 2016 | 15.21M |
| June 30, 2016 | 22.58M |
| March 31, 2016 | 25.53M |
| December 31, 2015 | 40.11M |
| September 30, 2015 | 52.67M |
| June 30, 2015 | 64.19M |
| March 31, 2015 | 71.92M |
| December 31, 2014 | 76.90M |
| September 30, 2014 | 16.19M |
| June 30, 2014 | |
| March 31, 2014 |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
| Johnson & Johnson | 201.06B |
| Eli Lilly & Co. | 142.28B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 90.01M |
| Shareholders Equity (Quarterly) | -82.49M |
| Debt to Equity Ratio | -0.6586 |
| Current Ratio | 0.0686 |
| Net Debt Paydown Yield | -162.8% |